Approved Symbol |
Approved Name |
Location |
Source |
ANAPC4 |
anaphase promoting complex subunit 4 |
4p15.31 |
Mapped by CNV |
UBE4A |
ubiquitination factor E4A |
11q23.3 |
Mapped by significant region |
MGRN1 |
mahogunin ring finger 1, E3 ubiquitin protein ligase |
16p13 |
Mapped by significant region |
UBE2H |
ubiquitin-conjugating enzyme E2H |
7q32 |
Mapped by LD-proxy |
UBE2I |
ubiquitin-conjugating enzyme E2I |
16p13.3 |
Mapped by significant region |
CBL |
Cbl proto-oncogene, E3 ubiquitin protein ligase |
11q23.3 |
Mapped by significant region |
SOCS1 |
suppressor of cytokine signaling 1 |
16p13.13 |
Mapped by significant region |
CDC26 |
cell division cycle 26 |
9q32 |
Mapped by significant region |
HERC2 |
HECT and RLD domain containing E3 ubiquitin protein ligase 2 |
15q13 |
Mapped by significant region |
FBXO4 |
F-box protein 4 |
5p12 |
Mapped by significant region |
BIRC6 |
baculoviral IAP repeat containing 6 |
2p22.3 |
Mapped by CNV |
UBE2L6 |
ubiquitin-conjugating enzyme E2L 6 |
11q12.1 |
Mapped by significant region |
BIRC2 |
baculoviral IAP repeat containing 2 |
11q22 |
Mapped by significant region |
SYVN1 |
synovial apoptosis inhibitor 1, synoviolin |
11q13 |
Mapped by significant region |
CUL5 |
cullin 5 |
11q22.3 |
Mapped by significant region; Mapped by PBA pathway |
PRPF19 |
pre-mRNA processing factor 19 |
11q12.2 |
Mapped by significant region |
UBOX5 |
U-box domain containing 5 |
20p13 |
Mapped by CNV |
TCEB2 |
transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) |
16p12.3 |
Mapped by significant region |
BIRC3 |
baculoviral IAP repeat containing 3 |
11q22 |
Mapped by significant region |
ERCC8 |
excision repair cross-complementing rodent repair deficiency, complementation group 8 |
5q12.1 |
Mapped by CNV |
NEDD4L |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
18q21 |
Mapped by significant region |
STUB1 |
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase |
16p13.3 |
Mapped by significant region |
TRIP12 |
thyroid hormone receptor interactor 12 |
2q36.3 |
Mapped by PBA pathway |
UBA6 |
ubiquitin-like modifier activating enzyme 6 |
4q13.2 |
Mapped by significant region |
MID1 |
midline 1 (Opitz/BBB syndrome) |
Xp22 |
Mapped by PBA pathway |
DDB1 |
damage-specific DNA binding protein 1, 127kDa |
11q12-q13 |
Mapped by significant region |
HERC3 |
HECT and RLD domain containing E3 ubiquitin protein ligase 3 |
4q21 |
Mapped by CNV |
SKP2 |
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase |
5p13 |
Mapped by significant region |
RCHY1 |
ring finger and CHY zinc finger domain containing 1, E3 ubiquitin protein ligase |
4q21.1-q21.3 |
Mapped by CNV |
UBE3A |
ubiquitin protein ligase E3A |
15q11.2 |
Mapped by CNV; Mapped by significant region |